Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 12, 2022 16:01 ET | Source: Science 37, Inc.

Science 37 Introduces Virtual Site Model to Rescue Slow Enrolling Clinical Trials

RESEARCH TRIANGLE PARK, N.C., May 12, 2022 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System™, today introduced a rapid-deployment virtual site...
May 10, 2022 07:55 ET | Source: Science 37, Inc.

Science 37® Extends Leadership in Decentralized Clinical Trial Market with NextGen SaaS Release to Fully Orchestrate Decentralized Study Conduct

RESEARCH TRIANGLE PARK, N.C., May 10, 2022 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System™, today introduced a milestone technology release,...
May 09, 2022 06:00 ET | Source: Science 37, Inc.

Science 37 Reports First Quarter 2022 Financial Results

RESEARCH TRIANGLE PARK, N.C., May 09, 2022 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), (“Science 37”) the Agile Clinical Trial Operating System™, today reported its financial...
April 25, 2022 07:55 ET | Source: Science 37, Inc.

Science 37 to Report First Quarter 2022 Financial Results on May 9, 2022

RESEARCH TRIANGLE PARK, N.C., April 25, 2022 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System™ today announced it will report first quarter...
March 31, 2022 07:55 ET | Source: Science 37, Inc.

Science 37® Adds Acclaimed Researcher and Oncologist, Dr. Shaalan Beg to Bolster Therapeutic Depth

RESEARCH TRIANGLE PARK, N.C., March 31, 2022 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System™ today announced it is fortifying its oncology...
March 22, 2022 07:00 ET | Source: Science 37, Inc.

Science 37 Reports Fourth Quarter and Full Year 2021 Financial Results

RESEARCH TRIANGLE PARK, N.C., March 22, 2022 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), (“Science 37”) the Agile Clinical Trial Operating System™, today reported its financial...
March 08, 2022 07:55 ET | Source: Science 37, Inc.

Science 37 to Report Fourth Quarter and Full Year 2021 Financial Results on March 22, 2022

RESEARCH TRIANGLE PARK, N.C., March 08, 2022 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System™ today announced it will report fourth quarter...
March 01, 2022 07:55 ET | Source: Science 37, Inc.

New Science 37® CNS Survey Confirms Growing Trend in Clinical Trials Landscape

RESEARCH TRIANGLE PARK, N.C., March 01, 2022 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System™, today published new CNS (Central Nervous...
February 24, 2022 07:55 ET | Source: Science 37, Inc.

Science 37®’s Operating System Receives ISO Certification for Information Security Management

RESEARCH TRIANGLE PARK, N.C., Feb. 24, 2022 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System™ today announced its Operating System has earned...
February 23, 2022 07:55 ET | Source: Science 37, Inc.

Science 37® to Present at the Cowen 42nd Annual Health Care Conference

RESEARCH TRIANGLE PARK, N.C., Feb. 23, 2022 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System™, today announced the company will be...